News in brief: Key Neurotech phase III trial underway; London dates confirmed for Cannabis Europa; Vitura sets AGM date by Steve Jones September 22, 2026September 24, 2026 Drug development firm Neurotech International (NTI) has dosed the first patient in its pivotal phase III […]
Driving reform battle moves to ACT but ‘today we celebrate’ say jubilant NSW campaigners by Steve Jones September 22, 2026September 22, 2026
Ahpra targets high-volume prescribing with new guidance by Adam Sheldon September 16, 2026September 17, 2026
‘The future of cannabis medicine’: Epsilon, Puro and Helix develop B2B product by Adam Sheldon September 15, 2026September 15, 2026
Start-up cultivator making ‘incredibly satisfying’ progress by Steve Jones September 10, 2026September 10, 2026
Chinese firm Yongji Health completes $31m takeover of Tasmanian Botanics by Steve Jones September 9, 2026September 9, 2026
‘Unpaid bills’ and ‘radio silence’: questions mount for Cannabis Warehouse amid co-founder dispute by Adam Sheldon and Steve Jones September 9, 2026September 10, 2026
Curaleaf questions Aurora share sales as hostile takeover fight escalates by Adam Sheldon September 9, 2026September 10, 2026
News in brief: Canopy expands Australian portfolio; Neurotech CEO departs; Elixinol completes US sale by Adam Sheldon September 8, 2026September 9, 2026
